Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3481710, 13 pages
https://doi.org/10.1155/2017/3481710
Research Article

Triethylenetetramine Synergizes with Pharmacologic Ascorbic Acid in Hydrogen Peroxide Mediated Selective Toxicity to Breast Cancer Cell

1Department of Reproduction Health and Infertility, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
3Canada-China-New Zealand Joint Laboratory of Maternal and Fetal Medicine, Chongqing Medical University, Chongqing 400016, China
4Molecular Medicine and Cancer Research Center, Department of Biochemistry and Molecular Biology, Chongqing Medical University, Chongqing 400016, China
5College of Medicine, University of Leicester, Leicester LE1 7RH, UK
6Laboratory of Lipid & Glucose Metabolism, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
7Laboratory of Reproductive Biology, School of Public Health and Management, Chongqing Medical University, Chongqing 400016, China

Correspondence should be addressed to Chao Tong; moc.361@umqcgnotoahc

Received 12 October 2016; Accepted 5 January 2017; Published 8 February 2017

Academic Editor: Lynne Postovit

Copyright © 2017 Lianlian Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Toyokuni, K. Okamoto, J. Yodoi, and H. Hiai, “Persistent oxidative stress in cancer,” FEBS Letters, vol. 358, no. 1, pp. 1–3, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Payne, B. Fogelgren, A. R. Hess et al., “Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism,” Cancer Research, vol. 65, no. 24, pp. 11429–11436, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. Weydert, T. A. Waugh, J. M. Ritchie et al., “Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth,” Free Radical Biology and Medicine, vol. 41, no. 2, pp. 226–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sen, B. Kawahara, and G. Chaudhuri, “Maintenance of higher H2O2 levels, and its mechanism of action to induce growth in breast cancer cells: important roles of bioactive catalase and PP2A,” Free Radical Biology and Medicine, vol. 53, no. 8, pp. 1541–1551, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. P.-J. Chua, G. W.-C. Yip, and B.-H. Bay, “Cell cycle arrest induced by hydrogen peroxide is associated with modulation of oxidative stress related genes in breast cancer cells,” Experimental Biology and Medicine, vol. 234, no. 9, pp. 1086–1094, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Rawal, S. R. Schroeder, B. A. Wagner et al., “Manganoporphyrins increase ascorbate-induced cytotoxicity by enhancing H2O2 generation,” Cancer Research, vol. 73, no. 16, pp. 5232–5241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Kuang, K. Balakrishnan, V. Gandhi, and X. Peng, “Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs,” Journal of the American Chemical Society, vol. 133, no. 48, pp. 19278–19281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. R. Buettner, “The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate,” Archives of Biochemistry and Biophysics, vol. 300, no. 2, pp. 535–543, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Jacobs, B. Hutton, T. Ng, R. Shorr, and M. Clemons, “Is there a role for oral or intravenous ascorbate (Vitamin C) in treating patients with cancer? A systematic review,” Oncologist, vol. 20, no. 2, pp. 210–223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Du, J. J. Cullen, and G. R. Buettner, “Ascorbic acid: chemistry, biology and the treatment of cancer,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1826, no. 2, pp. 443–457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G. R. Buettner and B. A. Jurkiewicz, “Catalytic metals, ascorbate and free radicals: combinations to avoid,” Radiation Research, vol. 145, no. 5, pp. 532–541, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. N. H. Williams and J. K. Yandell, “Reduction of oxidized cytochrome c by ascorbate ion,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 810, no. 2, pp. 274–277, 1985. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Chakravarty, K. Bhowmik, A. Mukherjee, and G. De, “Cu(2)O nanoparticles anchored on amine-functionalized graphite nanosheet: a potential reusable catalyst,” Langmuir, vol. 31, no. 18, pp. 5210–5219, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Lu, “Triethylenetetramine pharmacology and its clinical applications,” Molecular Cancer Therapeutics, vol. 9, no. 9, pp. 2458–2467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. V. K. Yellepeddi, K. K. Vangara, A. Kumar, and S. Palakurthi, “Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells,” Anticancer Research, vol. 32, no. 9, pp. 3651–3658, 2012. View at Google Scholar · View at Scopus
  17. D. P. G. Brown, H. Chin-Sinex, B. Nie, M. S. Mendonca, and M. Wang, “Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer,” Cancer Chemotherapy and Pharmacology, vol. 63, no. 4, pp. 723–730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Cui, I. Parra, M. Zhang et al., “Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance,” Cancer Research, vol. 66, no. 11, pp. 5950–5959, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Tong, A. Morrison, S. Mattison et al., “Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress,” FASEB Journal, vol. 27, no. 11, pp. 4332–4342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. P. T. Schumacker, “Reactive oxygen species in cancer cells: live by the sword, die by the sword,” Cancer Cell, vol. 10, no. 3, pp. 175–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. W. A. Wlassoff, C. D. Albright, M. S. Sivashinski, A. Ivanova, J. G. Appelbaum, and R. I. Salganik, “Hydrogen peroxide overproduced in breast cancer cells can serve as an anticancer prodrug generating apoptosis-stimulating hydroxyl radicals under the effect of tamoxifen-ferrocene conjugate,” Journal of Pharmacy and Pharmacology, vol. 59, no. 11, pp. 1549–1553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. D. W. Domaille, L. Zeng, and C. J. Chang, “Visualizing ascorbate-triggered release of labile copper within living cells using a ratiometric fluorescent sensor,” Journal of the American Chemical Society, vol. 132, no. 4, pp. 1194–1195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Hu, Z. Wu, G. Li et al., “The plasma level of retinol, vitamins A, C and α-tocopherol could reduce breast cancer risk? A meta-analysis and meta-regression,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 4, pp. 601–614, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Cahill, P. N. Corey, and A. El-Sohemy, “Vitamin C deficiency in a population of young canadian adults,” American Journal of Epidemiology, vol. 170, no. 4, pp. 464–471, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Jungert and M. Neuhäuser-Berthold, “The lower vitamin C plasma concentrations in elderly men compared with elderly women can partly be attributed to a volumetric dilution effect due to differences in fat-free mass,” British Journal of Nutrition, vol. 113, no. 5, pp. 859–864, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Olmedilla, F. Granado, S. Southon et al., “Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries,” British Journal of Nutrition, vol. 85, no. 2, pp. 227–238, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Yun, E. Mullarky, C. Lu et al., “Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH,” Science, vol. 350, no. 6266, pp. 1391–1396, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. Pires, C. R. Marques, J. C. Encarnação et al., “Ascorbic acid and colon cancer: an oxidative stimulus to cell death depending on cell profile,” European Journal of Cell Biology, vol. 95, no. 6-7, pp. 208–218, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. J. A. Cieslak and J. J. Cullen, “Treatment of pancreatic cancer with pharmacological ascorbate,” Current Pharmaceutical Biotechnology, vol. 16, no. 9, pp. 759–770, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Guerriero, A. Sorice, F. Capone et al., “Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines,” PLoS ONE, vol. 9, no. 12, Article ID e115287, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Lixia, Y. Fei, J. Jiajia, and L. Jianhui, “Triethylene tetramine, a novel ligand of G-quadruplex, induces senescence of MCF-7 cells,” Biotechnology Letters, vol. 30, no. 1, pp. 47–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. E. D. Harris, “A requirement for copper in angiogenesis,” Nutrition Reviews, vol. 62, no. 2, pp. 60–64, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. T. Hyvönen, S. Ucal, M. Pasanen et al., “Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation,” Biochemical Journal, vol. 473, no. 10, pp. 1433–1441, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Kadowaki, D. Endoh, T. Okui, and M. Hayashi, “Trientine, a Copper-chelating agent, induced apoptosis in murine fibrosarcoma cells by activation of the p38 MAPK pathway,” Journal of Veterinary Medical Science, vol. 71, no. 11, pp. 1541–1544, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. P. K. S. Mahalingaiah, L. Ponnusamy, and K. P. Singh, “Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells,” Breast Cancer Research and Treatment, vol. 153, no. 1, pp. 41–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. P. K. Mahalingaiah and K. P. Singh, “Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells,” PLoS ONE, vol. 9, no. 1, Article ID e87371, 2014. View at Publisher · View at Google Scholar
  37. F. Liu, S. Ge, J. Yu, M. Yan, and X. Song, “Electrochemical device based on a Pt nanosphere-paper working electrode for in situ and real-time determination of the flux of H2O2 releasing from SK-BR-3 cancer cells,” Chemical Communications, vol. 50, no. 71, pp. 10315–10318, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Osmak, I. Kovaček, I. Ljubenkov, R. Spaventi, and M. Eckert-Maksić, “Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: potential anticancer drugs,” Neoplasma, vol. 44, no. 2, pp. 101–107, 1997. View at Google Scholar · View at Scopus
  39. J. Gao, X. Liu, F. Yang, T. Liu, Q. Yan, and X. Yang, “By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis,” Oncotarget, vol. 6, no. 29, pp. 27187–27198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. N. R. Treff, D. Pouchnik, G. A. Dement, R. L. Britt, and R. Reeves, “High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells,” Oncogene, vol. 23, no. 3, pp. 777–785, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. M. Kalle, A. Mallika, J. Badiger, Alinakhi, P. Talukdar, and Sachchidanand, “Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 401, no. 1, pp. 13–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Al Dhaheri, S. Attoub, K. Arafat et al., “Salinomycin induces apoptosis and senescence in breast cancer: upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation,” Biochimica et Biophysica Acta, vol. 1830, no. 4, pp. 3121–3135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Ourique, M. R. Kviecinski, K. B. Felipe et al., “DNA damage and inhibition of akt pathway in MCF-7 cells and ehrlich tumor in mice treated with 1,4-naphthoquinones in combination with ascorbate,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 495305, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Ma, W.-Z. Zhu, T.-T. Liu et al., “H2O2 inhibits proliferation and mediates suppression of migration via DLC1/RhoA signaling in cancer cells,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 4, pp. 1637–1642, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. M. W. Roomi, T. Kalinovsky, N. M. Roomi, J. Cha, M. Rath, and A. Niedzwiecki, “In vitro and in vivo effects of a nutrient mixture on breast cancer progression,” International Journal of Oncology, vol. 44, no. 6, pp. 1933–1944, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. A. R. Kennedy, J. H. Ware, W. Carlton, and J. G. Davis, “Suppression of the later stages of radiation-induced carcinogenesis by antioxidant dietary formulations,” Radiation Research, vol. 176, no. 1, pp. 62–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Charalabopoulos, S. Karkabounas, P. Dimicco et al., “The role of ascorbic acid, selenium, and glutathione on benzo[a]pyrene-induced carcinogenesis in wistar rats,” Journal of BUON, vol. 9, pp. 187–192, 2004. View at Google Scholar
  48. P. Gao, H. Zhang, R. Dinavahi et al., “HIF-dependent antitumorigenic effect of antioxidants in vivo,” Cancer Cell, vol. 12, no. 3, pp. 230–238, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Kim, O.-N. Bae, S.-H. Koh et al., “High-dose vitamin C injection to cancer patients may promote thrombosis through procoagulant activation of erythrocytes,” Toxicological Sciences, vol. 147, no. 2, pp. 350–359, 2015. View at Publisher · View at Google Scholar · View at Scopus